<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tan Z</submitter><funding>National Science Foundation of China</funding><funding>Natural Science Foundation of Shaanxi Province</funding><funding>Science Foundation for Distinguished Young Scholars of Shaanxi Province</funding><pagination>228</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9306173</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>41(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Abnormal glycosylation in a variety of cancer types is involved in tumor progression and chemoresistance. Glycosyltransferase C1GALT1, the key enzyme in conversion of Tn antigen to T antigen, is involved in both physiological and pathological conditions. However, the mechanisms of C1GALT1 in enhancing oncogenic phenotypes and its regulatory effects via non-coding RNA are unclear.&lt;h4>Methods&lt;/h4>Abnormal expression of C1GALT1 and its products T antigen in human bladder cancer (BLCA) were evaluated with BLCA tissue, plasma samples and cell lines. Effects of C1GALT1 on migratory ability and proliferation were assessed in YTS-1 cells by transwell, CCK8 and colony formation assay in vitro and by mouse subcutaneous xenograft and trans-splenic metastasis models in vivo. Dysregu</pubmed_abstract><journal>Journal of experimental &amp; clinical cancer research : CR</journal><pubmed_title>Dysregulation and prometastatic function of glycosyltransferase C1GALT1 modulated by cHP1BP3/ miR-1-3p axis in bladder cancer.</pubmed_title><pmcid>PMC9306173</pmcid><funding_grant_id>2021JC-39</funding_grant_id><funding_grant_id>31971211</funding_grant_id><funding_grant_id>81802654</funding_grant_id><funding_grant_id>32071274</funding_grant_id><funding_grant_id>2022JQ-205</funding_grant_id><funding_grant_id>2019JZ-22</funding_grant_id><pubmed_authors>Cao L</pubmed_authors><pubmed_authors>Wu J</pubmed_authors><pubmed_authors>Lin S</pubmed_authors><pubmed_authors>Dong Z</pubmed_authors><pubmed_authors>Guan F</pubmed_authors><pubmed_authors>Zhou X</pubmed_authors><pubmed_authors>Zhao Z</pubmed_authors><pubmed_authors>Ye Z</pubmed_authors><pubmed_authors>Zhou Z</pubmed_authors><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Tan Z</pubmed_authors><pubmed_authors>Feng H</pubmed_authors><pubmed_authors>Liang L</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Song Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dysregulation and prometastatic function of glycosyltransferase C1GALT1 modulated by cHP1BP3/ miR-1-3p axis in bladder cancer.</name><description>&lt;h4>Background&lt;/h4>Abnormal glycosylation in a variety of cancer types is involved in tumor progression and chemoresistance. Glycosyltransferase C1GALT1, the key enzyme in conversion of Tn antigen to T antigen, is involved in both physiological and pathological conditions. However, the mechanisms of C1GALT1 in enhancing oncogenic phenotypes and its regulatory effects via non-coding RNA are unclear.&lt;h4>Methods&lt;/h4>Abnormal expression of C1GALT1 and its products T antigen in human bladder cancer (BLCA) were evaluated with BLCA tissue, plasma samples and cell lines. Effects of C1GALT1 on migratory ability and proliferation were assessed in YTS-1 cells by transwell, CCK8 and colony formation assay in vitro and by mouse subcutaneous xenograft and trans-splenic metastasis models in vivo. Dysregu</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2025-04-05T14:26:04.3Z</modification><creation>2024-11-13T05:50:37.508Z</creation></dates><accession>S-EPMC9306173</accession><cross_references><pubmed>35864552</pubmed><doi>10.1186/s13046-022-02438-7</doi></cross_references></HashMap>